Viscoelastic Hemostatic Monitoring for Real-Time Coagulation Management

You are reading version 1 of this direction, frozen 2026-10-04. The latest version is version 2.

Version 1 of 213 papers23 conceptsfrozen 2026-10-04

Traditional coagulation assessments, such as Prothrombin Time (PT) or International Normalized Ratio (INR), are often described as "static snapshots." These tests measure the time it takes for plasma to reach the very beginning of fibrin formation in a controlled lab environment. However, as noted by Shichun Wang and colleagues, these metrics fail to capture the "dynamic lifecycle" of a clot—its strengthening, its stability, and its eventual breakdown (fibrinolysis).

The research direction represented here focuses on viscoelastic hemostatic assays (VHAs), such as Thromboelastography (TEG) and Thromboelastometry (ROTEM). These tools shift the diagnostic focus from isolated protein concentrations to the physical, functional properties of whole blood as it clots in real-time.

From Static Counts to Functional Mechanics

The core intuition behind VHAs is that blood clotting is a mechanical process, not just a chemical one. While a standard lab test might tell you that a patient has a low platelet count, it cannot tell you how effectively those remaining platelets are interacting with fibrin to create a stable plug.

VHAs measure the viscoelastic properties—the changing resistance and elasticity—of a blood sample as it transitions from a liquid to a gel and back again. By monitoring the physical impedance of the blood, researchers like Ajit Kumar Singh can detect subtle shifts in the coagulation profile that precede clinical bleeding, providing a "sensitive signature" of the clotting process that standard tests overlook.

Capturing the Full Clot Lifecycle

A major advantage of this approach is its ability to visualize the entire lifespan of a clot. Shichun Wang emphasizes that VHAs provide a more physiologically accurate representation by accounting for the interactions between plasma factors and cellular components like platelets.

Key metrics derived from these assays include:

  • Reaction Time (R-value): The time until the first detectable clot formation.
  • Maximum Amplitude (MA): The peak strength of the clot, representing the combined contribution of platelets and fibrinogen. Qinglin Zhang uses this to quantify thrombotic risk in inflammatory conditions.
  • Lysis: The rate at which the clot dissolves, which is critical for identifying hyperfibrinolysis in trauma or surgery.

Precision Medicine at the Bedside

Because VHAs are often point-of-care (POC) technologies, they allow for "goal-directed therapy." In the POCKET trial protocol, Leonardo Lima Rocha explains how this allows clinicians to identify specific functional deficiencies and administer only the necessary blood products.

The impact of this precision is significant. Pierre Tibi demonstrated that implementing ultrasound-based viscoelastic testing (the Quantra system) led to a 97% reduction in plasma transfusions in cardiac surgery. By isolating whether a bleed is caused by low fibrinogen or poor platelet function in under 15 minutes, medical teams can treat the cause rather than the symptom.

Identifying Hidden Risks

Standard tests can provide a "false sense of security." Jianjun Zhang found that COVID-19 survivors with coronary artery disease remained in a hypercoagulable state detectable by dynamic whole-blood assessments even when traditional plasma tests appeared normal. Similarly, in traumatic brain injury, Julia K. Böhm uses dynamic assays to reveal "counterbalanced" derangements—where clotting factors are consumed while clot-dissolving activity surges—capturing a kinetic capacity that static snapshots miss entirely.

Papers in this version

History & citationVersion 2 · 2026-10-04

Current · Permanent link

  1. Version 2 (latest) · 2026-10-04 · 14 papers
  2. Version 1 · 2026-10-04 · 13 papers
Cite this direction

Latest version (a living page):

@misc{lacuna_viscoelastic_hemostatic_assay_0cab47dd,
  title = {viscoelastic hemostatic assay},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/viscoelastic-hemostatic-assay/rdr_0cab47dddca64b2797af58f6058af01c},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_viscoelastic_hemostatic_monitoring_for_r_0cab47dd_v1,
  title = {Viscoelastic Hemostatic Monitoring for Real-Time Coagulation Management},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/viscoelastic-hemostatic-monitoring-for-real-time-coagulation-management/rdr_0cab47dddca64b2797af58f6058af01c/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}